Antioxidant capacity and fragmentation features of C‐glycoside isoflavones by high‐resolution electrospray ionization tandem mass spectrometry using collision‐induced and high‐energy collisional dissociation techniques

Table S1. Chemical shifts of orobol-8-C-β-glycoside and orobol-8-C-β-glycoside isolated by preparative HPLC from crude extract of Dalbergia monetaria

Table S2. ESI-CID-MSn fragmentation in negative and positive modes of ionization of orobol C-glycosides from D. monetaria. In parenthesis the relative abundance values (%) are indicated.

Table S3. ESI-CID-MS2, at 10 to 60 eV, in positive mode of ionization of orobolC-glycosides isolated from D. monetaria. In parenthesis the relative abundance values (%) are indicated.

Table S4. ESI-HCD-MS2 in negative and positive modes of ionization of orobolC-glycosides from D. monetaria. In parenthesis the relative abundance values (%) are indicated.

Figure S1. HR CID-MS2, negative mode of ionization, at 25 eV of m/z 447 of orobol-C-glycoside derivatives

Figure S2. HR CID-MS3, negative mode of ionization, at 30 eV of m/z 327 (from MS2 447) of orobol-C-glycoside derivatives

Figure S3. HR CID-MS4, negative mode of ionization, at 30 eV of m/z 299 (from MS2 447; MS3 327) of orobol-C-glycoside derivatives

Figure S4. HR CID-MS5, negative mode of ionization, at 30 eV of m/z 271 (from MS2 447; MS3 327; MS4 299) of orobol-C-glycoside derivatives

Figure S5. HR CID-MS2, positive mode of ionization, at 25 eV of m/z 449 of orobol-C-glycoside derivatives

Figure S6. HR CID-MS3, positive mode of ionization, at 30 eV of m/z 431 (from MS2 449) of orobol-C-glycoside derivatives

Figure S7. HR CID-MS4, positive mode of ionization, at 30 eV of m/z 413 (from MS2 449; MS3 431) of orobol-C-glycoside derivatives

Figure S8. HR CID-MS4, positive mode of ionization, at 30 eV of m/z 383 (from MS2 449; MS3 431) of orobol-C-glycoside derivatives

Figure S9. HR CID-MS4, positive mode of ionization, at 30 eV of m/z 353 (from MS2 449; MS3 431) of orobol-C-glycoside derivatives

Figure S10. HR CID-MS4, positive mode of ionization, at 30 eV of m/z 311 (from MS2 449; MS3 431) of orobol-C-glycoside derivatives

Figure S11. HR CID-MS5, positive mode of ionization, at 35 eV of m/z 325 (from MS2 449; MS3 431; MS4 353) of orobol-C-glycoside derivatives

Figure S12. HR CID-MS5, positive mode of ionization, at 35 eV of m/z 395 (from MS2 449; MS3 431; MS4 413) of orobol-C-glycoside derivatives

Figure S13. CID-MS2, positive mode of ionization, of m/z 449 at 10 eV of orobol-C-glycoside derivatives

Figure S14. CID-MS2, positive mode of ionization, of m/z 449 at 15 eV of orobol-C-glycoside derivatives

Figure S15. CID-MS2, positive mode of ionization, of m/z 449 at 20 eV of orobol-C-glycoside derivatives

Figure S16. CID-MS2, positive mode of ionization, of m/z 449 at 30 eV of orobol-C-glycoside derivatives

Figure S17. CID-MS2, positive mode of ionization, of m/z 449 at 40 eV of orobol-C-glycoside derivatives

Figure S18. CID-MS2, positive mode of ionization, of m/z 449 at 50 eV of orobol-C-glycoside derivatives

Figure S19. CID-MS2, positive mode of ionization, of m/z 449 at 60 eV of orobol-C-glycoside derivatives

Figure S20. HCD-MS2, negative mode of ionization, of m/z 447 at 50 eV of orobol-C-glycoside derivatives

Figure S21. HCD-MS2, positive mode of ionization, of m/z 449 at 80 eV of orobol-C-glycoside derivatives

留言 (0)

沒有登入
gif